DSRU Scientific Publications
Use our keyword search facility to match our publications with your area of interest.
253 publications found, showing 21 to 40
-
Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.
Twaites B, Wilton LV, Layton D, Shakir SA.
Acta Diabetol. December 2007 -
A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.
Perrio MJ, Wilton LV, Shakir SA.
Drug Saf. September 2007 -
The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.
Twaites BR, Wilton LV, Shakir SA.
J Psychopharmacol. September 2007 -
Thoughts on signal detection in pharmacovigilance
Shakir SA.
Drug Saf. September 2007 -
A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring.
Perrio MJ, Wilton LV, Shakir SA.
Pharmacoepidemiol Drug Saf. September 2007 -
The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
Twaites BR, Wilton LV, Shakir SA,
J Psychopharmacol. June 2007 -
Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
Twaites BR, Wilton LV, Shakir SA.
Drug Saf. May 2007 -
An analysis of the exclusion criteria used in observational pharmacoepidemiological studies
Perrio M, Waller PC, Shakir SA,
Pharmacoepidemiol Drug Saf. March 2007 -
Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance
Perrio M, Voss S, Shakir SA.
Drug Saf. February 2007 -
Prescription-event Monitoring
Shakir SAW,
Pharmacovigilance. February 2007 -
An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
Hazell L, Boshier A, Harris S, Wilton LV, Shakir SA.
BJU Int. February 2007 -
Safety profile of rosuvastatin : results of a prescription-event monitoring study of 11 680 patients
Kasliwal R, Wilton LV, Cornelius V, urich-Barrera B, Shakir SA,
Drug Saf. February 2007 -
Safety profile of orlistat: results of a prescription-event monitoring study
Acharya NV, Wilton LV, Shakir SA,
Int J Obes (Lond). November 2006 -
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes
Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, av-Citrin O, Kennedy D, Voyer LS, De SM, Einarson A,
J Clin Psychiatry. August 2006 -
Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction
Maclennan KM, Boshier A, Wilton LV, Shakir SA,
BJU Int. July 2006 -
Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study
Marshall V, Wilton L, Shakir S,
Acta Diabetol. May 2006 -
Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England
Layton D, Marshall V, Boshier A, Friedmann P, Shakir SA,
Drug Saf. January 2006 -
An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets
Clarke A, Deeks JJ, Shakir SA,
Drug Saf. January 2006 -
Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England
urich-Barrera B, Wilton L, Harris S, Shakir SA,
Drug Saf. January 2006 -
Under-reporting of adverse drug reactions : a systematic review
Hazell L, Shakir SA,
Drug Saf. January 2006